性别、膀胱癌医疗保健和 COVID-19 负担。
Gender, Bladder Cancer Healthcare and Burden of COVID-19.
机构信息
Department of Gynecology, Faculty of Medicine, Hamadan university of Medical Sciences, Hamadan, Iran.
Department of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
出版信息
Cancer Invest. 2023 Jan;41(1):58-69. doi: 10.1080/07357907.2022.2140351. Epub 2022 Nov 2.
Bladder cancer as one of the main comorbid diseases might be more susceptible to develop COVID-19 infection with a higher mortality risk during the COVID-19 pandemic. The European Association of Urology (EAU) recommended a comprehensive panel for bladder cancer diagnosis and treatment during this global health problem. The urgent need for treatments of COVID-19 during the pandemic has persuaded researchers to evaluate the different medications, which may lead to drug shortages. Therefore, in this review paper, we have focused on the least recommendations of EAU about bladder cancer during of COVID-19 pandemic to provide a comprehensive panel for high-risk patients.
膀胱癌作为主要合并症之一，在 COVID-19 大流行期间可能更容易感染 COVID-19，且死亡率更高。欧洲泌尿外科学会（EAU）建议在全球卫生问题期间，对膀胱癌的诊断和治疗制定一个全面的方案。在大流行期间对 COVID-19 治疗的迫切需求促使研究人员评估不同的药物，这可能导致药物短缺。因此，在这篇综述文章中，我们重点关注 EAU 在 COVID-19 大流行期间对膀胱癌的最低建议，为高危患者提供一个全面的方案。
Zotero 插件